Michel Lagarde
Director
Mr. Lagarde joined our board in 2023. He currently serves as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific Inc., a supplier of analytical instruments, life sciences solutions, specialty diagnostics, and laboratory, pharmaceutical and biotechnology services. He is responsible for Thermo Fisher’s Pharma Services, Customer Channels, BioProduction, Analytical Instruments, Laboratory Products and Clinical Research businesses as well as its Corporate Accounts function and Chief Medical Office. He joined Thermo Fisher as Senior Vice President and President, Pharma Services, in 2017 through its acquisition of Patheon N.V., a pharma services company. Prior to Thermo Fisher, Mr. Lagarde was President and Chief Operating Officer at Patheon from 2016 to 2017 and Managing Director at JLL Partners, a private equity firm investing in health care services, from 2008 to 2016. Prior to JLL, he spent 12 years at Philips, a global leader in health technology, in various finance roles across several international markets. Mr. Lagarde holds a Bachelor of Business Administration (BBA) from European University in Antwerp, Belgium, and an executive master’s degree in finance and control from Maastricht Universiteit in the Netherlands.
Mr. Lagarde joined our board in 2023. He currently serves as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific Inc., a supplier of analytical instruments, life sciences solutions, specialty diagnostics, and laboratory, pharmaceutical and biotechnology services. He is responsible for Thermo Fisher’s Pharma Services, Customer Channels, BioProduction, Analytical Instruments, Laboratory Products and Clinical Research businesses as well as its Corporate Accounts function and Chief Medical Office. He joined Thermo Fisher as Senior Vice President and President, Pharma Services, in 2017 through its acquisition of Patheon N.V., a pharma services company. Prior to Thermo Fisher, Mr. Lagarde was President and Chief Operating Officer at Patheon from 2016 to 2017 and Managing Director at JLL Partners, a private equity firm investing in health care services, from 2008 to 2016. Prior to JLL, he spent 12 years at Philips, a global leader in health technology, in various finance roles across several international markets. Mr. Lagarde holds a Bachelor of Business Administration (BBA) from European University in Antwerp, Belgium, and an executive master’s degree in finance and control from Maastricht Universiteit in the Netherlands.